top of page

For Animal Health Only


Perfusion Solution

COMPOSITION: Each ml of clear, golden-orange aqueous solution contains

     _cc781905-5cde-3194-bb3b-136bad-136bad5cf3b-136d58359cf1365cf583594cc781905-5cde-3194-bb3b-136bad-136bad5cf1365cf78359cc1365359cc58359cf1365cde78359cc78195 5cde-3194-bb3b-136bad5cf58d_  Metamizole sodium

40.00mg mg

     _cc781905-5cde-3194-bb3b-136bad-136bad5cf3b-136d58359cf1365cf583594cc781905-5cde-3194-bb3b-136bad-136bad5cf1365cf78359cc1365359cc58359cf1365cde78359cc78195 5cde-3194-bb3b-136bad5cf58d_   _cc7894__cf58d_cc7894cf58d_cc7894_f58cf375cde-3194-bb3b-136bad5cf58d_cc7894__cf58359-cc7894__cf58359cfcf7894_cf58359cc7894cf58cde_cfcf7894cf58359cde-3194-3194-bb3b-36bad5cf58d__cc7894-3194-bb3b-b-36 -3194-bb3b-136bad5cf58d_ 


     _cc781905-5cde-3194-bb3b-136bad-136bad5cf3b-136d58359cf1365cf583594cc781905-5cde-3194-bb3b-136bad-136bad5cf1365cf78359cc1365359cc58359cf1365cde78359cc78195 5cde-3194-bb3b-136bad5cf58d_  Calcium gluconate

100.00mg mg

     _cc781905-5cde-3194-bb3b-136bad-136bad5cf3b-136d58359cf1365cf583594cc781905-5cde-3194-bb3b-136bad-136bad5cf1365cf78359cc1365359cc58359cf1365cde78359cc78195 5cde-3194-bb3b-136bad5cf58d_  Magnesium gluconate

10.00mg mg

     _cc781905-5cde-3194-bb3b-136bad-136bad5cf3b-136d58359cf1365cf583594cc781905-5cde-3194-bb3b-136bad-136bad5cf1365cf78359cc1365359cc58359cf1365cde78359cc78195 5cde-3194-bb3b-136bad5cf58d_  Sodium dihydrogen phosphate dihydrate


     _cc781905-5cde-3194-bb3b-136bad-136bad5cf3b-136d58359cf1365cf583594cc781905-5cde-3194-bb3b-136bad-136bad5cf1365cf78359cc1365359cc58359cf1365cde78359cc78195 5cde-3194-bb3b-136bad5cf58d_  Acetylethionine

40.00mg mg

     _cc781905-5cde-3194-bb3b-136bad-136bad5cf3b-136d58359cf1365cf583594cc781905-5cde-3194-bb3b-136bad-136bad5cf1365cf78359cc1365359cc58359cf1365cde78359cc78195 5cde-3194-bb3b-136bad5cf58d_  Glucose monohydrate

(18    (equivalent to 1.82mg Glucose)

200.00 mg mg


     _cc781905-5cde-3194-bb3b-136bad-136bad5cf3b-136d58359cf1365cf583594cc781905-5cde-3194-bb3b-136bad-136bad5cf1365cf78359cc1365359cc58359cf1365cde78359cc78195 5cde-3194-bb3b-136bad5cf58d_  Excipients whose knowledge is essential for the safe use of the preparation:

     _cc781905-5cde-3194-bb3b-136bad-136bad5cf3b-136d58359cf1365cf583594cc781905-5cde-3194-bb3b-136bad-136bad5cf1365cf78359cc1365359cc58359cf1365cde78359cc78195 5cde-3194-bb3b-136bad5cf58d_  10.5 mg of benzyl alcohol, boric acid, water for injection



SPECIAL CLINICAL INFORMATION AND SPECIAL WARNINGS FOR TARGET SPECIES:Slow intravenous (IV) infusion should be provided at body temperature by observing the heartbeat. If tachycardia or cardiac arrhythmia occurs, the infusion should be stopped. Attention should be paid to general asepsis and antisepsis during application. Use in pregnancy and lactation: Novacoc can be administered to pregnant women and lactating animals.


There are no side effects or undesirable effects of the product. If the infusion rate is too high and the solution is at temperatures below body temperature, tachycardia and cardiac arrhythmia may occur.


Increased amounts of calcium may potentiate the effect of cardiac glycosides and adrenergics (etilephrine). Cardiac arrhythmia may occur as a result of concomitant use with inhalation anesthetics. Metamizole can increase the effect of anticoagulants, weaken the effect of furosemide. Magnesium gluconate weakens the action of aminoglycosides and tetracyclines, and enhances the neuromuscular-blocking effect of aminoglycosides and inhalation anesthetics. Caffeine enhances the action of cardiac glycosides. It should not be mixed with other drugs intended for parenteral administration.

SYMPTOMS OF OVERDOSE, PRECAUTIONS AND ANTIDOTE: Undesirable effects are mainly due to incorrect infusions (if the infusion rate is too high and/or the solution is at temperatures below body temperature). As a result, circulatory collapse, cardiac arrhythmia, labored breathing, spasms, and muscle weakness may develop. In such cases, the infusion is stopped and, if necessary, symptomatic treatment is started.


Drug Residue Clearance Time (withdrawal); During the treatment and after the last drug application, cattle raised for meat should not be sent to slaughter before 13 days, horses 6 days, and pigs 3 days later. Cow milk obtained during the treatment and until 5 milkings (2.5 days) after the last drug administration  should not be offered for human consumption. It is not used in mares producing milk for human consumption.

GENERAL WARNINGS:Consult your veterinarian before use and in case of an unexpected effect.

Keep out of reach of children. Keep away from foodstuffs.

PRECAUTIONS TO BE TAKEN BY THE APPLICANT AND WARNINGS FOR PHYSICIANS:In case of accidental self-injection by the practitioner, a physician should be consulted with the package insert.


  • Cattle and Horse

bottom of page